knowcompoundschlorogenic acid
Specimen compoundPlate I
Chlorogenic acid

- ChEBI
- CHEBI:16112
- PubChem CID
- 1794427
↑ raised 1 finding in 1 endpoint · ↓ lowered 4 in 2
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 0
- Limited
- 0
- Very limited
- 5
- Insufficient
- 0
Chlorogenic acid
Most findings
- Diastolic blood pressure×2
- Systolic blood pressure×2
- Plasma total homocysteine (tHcy) concentration×1
36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · findings
What chlorogenic acid moved, and by how much
- MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
5 shown
- Plasma total homocysteine (tHcy) concentrationMoved: raisesEffect, as reportedMD0.4[0 to 0.8]Evidence: Very limitedPaper: PMID 112379282001
- Who
- healthy men and women; fasting plasma collected 20 h after supplement intake
- Dose studied
- chlorogenic acid 2 g (5.5 mmol) daily for 7 days
Total homocysteine in fasting plasma collected 20 h after supplement intake was 4% (0.4 micromol/L; 95% CI: 0.0, 0.8) higher after chlorogenic acid and 5% (0.5 micromol/L; 95% CI: 0.0, 0.9) higher after black tea than after placebo.”
Quoted verbatim from Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans.crossover · 7 daysPermalink - Diastolic blood pressureMoved: lowersEffect, as reportedMD−3.68[−3.91 to −3.45]Evidence: Very limitedreplicated ×1Paper: PMID 249432892015
- Who
- participants of pooled randomised clinical trials, all in Asian populations
- Dose studied
- not reported
Meta-analysis also showed a significant reduction in diastolic blood pressure favouring CGA (MD: -3.68 mm Hg; 95% CI: -3.91 to -3.45; I(2)=97%; P<0.00001).”
Quoted verbatim from The effect of chlorogenic acid on blood pressure: a systematic review and meta-analysis of randomized clinical trials.meta-analysisPermalink - Systolic blood pressureMoved: lowersEffect, as reportedMD−2.41[−4.78 to −0.03]Evidence: Very limitedreplicated ×1Paper: PMID 229007022012
- Who
- healthy men and women; single acute dose, blood pressure measured post-treatment
- Dose studied
- chlorogenic acid 400 mg, single acute dose
Relative to control, the mean post-treatment systolic blood pressure (-2.41 mmHg, 95% CI: -0.03, -4.78; P = 0.05) and diastolic blood pressure (-1.53 mmHg, 95% CI: -0.05, -3.01; P = 0.04) were significantly lower with chlorogenic acid.”
Quoted verbatim from Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: a randomized trial.crossoverPermalink - Systolic blood pressureMoved: lowersEffect, as reportedMD−4.31[−5.6 to −3.01]Evidence: Very limitedreplicated ×1Paper: PMID 249432892015
- Who
- participants of five pooled randomised clinical trials, all in Asian populations
- Dose studied
- not reported
Meta-analysis revealed a statistically significant reduction in systolic blood pressure in favour of CGA (mean difference (MD): -4.31 mm Hg; 95% confidence interval (CI): -5.60 to -3.01; I(2)=65%; P<0.00001).”
Quoted verbatim from The effect of chlorogenic acid on blood pressure: a systematic review and meta-analysis of randomized clinical trials.meta-analysisPermalink - Diastolic blood pressureMoved: lowersEffect, as reportedMD−1.53[−3.01 to −0.05]Evidence: Very limitedreplicated ×1Paper: PMID 229007022012
- Who
- healthy men and women; single acute dose, blood pressure measured post-treatment
- Dose studied
- chlorogenic acid 400 mg, single acute dose
Relative to control, the mean post-treatment systolic blood pressure (-2.41 mmHg, 95% CI: -0.03, -4.78; P = 0.05) and diastolic blood pressure (-1.53 mmHg, 95% CI: -0.05, -3.01; P = 0.04) were significantly lower with chlorogenic acid.”
Quoted verbatim from Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: a randomized trial.crossoverPermalink
No row matches these filters.
No dose is advised.
- MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
What the reference databases state
- Reactions · Rhea
- 4reactions
4Reactions
04 · on the label · 48 products
Labelled products
Source: NIH DSLD · Ingredient: chlorogenic acid · 48 products · Declared amount per serving: 2.5–556 mg
36 labels state an amount12 do not
- Ab Cuts Sleek & LeanThermo Rise 0275 mgper 2 softgelsDSLD:23446
- AOR Advanced Orthomolecular Research AdvancedOrtho Heart100 mgper 1 capsuleDSLD:214844
- Foster RegalGreen Coffee Bean Extract 800 mg50%400 mgper 2 vegetable capsulesDSLD:260148
- FuturebioticsGreen Coffee Extract 400 mg200 mgper 1 vegetarian capsuleDSLD:259108
- Garden of LifefucoTHIN GREEN400 mgper 1 capsuleDSLD:321336
- Garden of LifefucoTHIN GREEN400 mgper 1 capsuleDSLD:83224
- GNC AMP Advanced Muscle PerformanceDecaf Thermo Igniter 12X45%90 mgper 1 yellow capletDSLD:312711
- GNC AMP Advanced Muscle PerformanceDecaf Thermo Igniter 12X45%90 mgper 1 yellow tabletDSLD:336011
- GT Genesis TodayNature Trim 590 mgper 3 capsulesDSLD:73922
- Herb PharmGuayusaprovided120 mgper 1 capsuleDSLD:327355
- Hi-Tech PharmaceuticalsGlucozene-Rxbeansamount not statedper 1 capletDSLD:10207
- HydroxycutHydroxycut +Womenstandardized for 45% chlorogenic acidsamount not statedper 2 rapid-release liquid capsulesDSLD:325594
Show the remaining 36Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
05 · the record
Sources
35
papers screened for chlorogenic acid
- admitted
- 4
- read and discarded
- 15
- not read yet
- 16
Sources cited
3 papers · 5 findings
1 admitted at screening, no finding yet